Dongyang Guangyao submitted a prospectus and plans to list in Hong Kong in an introduction manner.

Golden Ten Data December 12th news, on December 11th, Dongyang Sunshine Jianghan Pharmaceutical Holdings Co., Ltd., a major shareholder of Dongyang Sunshine Pharmaceutical, submitted a prospectus to the Hong Kong Stock Exchange, intending to list in Hong Kong through an introduction method, with China International Capital Corporation as the exclusive sponsor.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)